Evaluation of curcumin acetates and amino acid conjugates as proteasome inhibitors
- PMID: 20818481
- PMCID: PMC3306612
- DOI: 10.3892/ijmm_00000484
Evaluation of curcumin acetates and amino acid conjugates as proteasome inhibitors
Abstract
Curcumin (diferuloylmethane) is the main active ingredient of turmeric, a traditional herbal medicine and food of south Asia. Curcumin has been found to have a wide range of biological activities, including antioxidant, anti-inflammatory, chemopreventive and chemotherapeutic activities. Curcumin is currently being tested in clinical trials for treatment of various types of cancers, including multiple myeloma, pancreatic cancer and colon cancer. Although no toxicity associated with curcumin (even at very high doses) has been observed, the effects of curcumin in other solid tumors have been modest, primarily due to poor water solubility and poor bioavailability in tissues remote from the gastrointestinal tract. Therefore, there is a need for the discovery of curcumin analogs with better water solubility or greater bioavailability for the treatment of solid tumors such as prostate cancer. In this study, curcumin acetates and amino acid conjugates of curcumin were studied in terms of their proteasome inhibitory and antiproliferative effects against several human cancer cell lines. It was found that the water soluble amino acid conjugates of curcumin showed a potent antiproliferative effect and are potent proteasome inhibitors. Docking studies of the curcumin amino acid conjugates for proteasome inhibition were carried out to explain their biological activities. It is suggested that they may serve as the water soluble analogs of curcumin.
Figures
Similar articles
-
Synthesis and biological evaluation of curcumin derivatives modified with α-amino boronic acid as proteasome inhibitors.Bioorg Med Chem Lett. 2018 Aug 1;28(14):2459-2464. doi: 10.1016/j.bmcl.2018.06.004. Epub 2018 Jun 2. Bioorg Med Chem Lett. 2018. PMID: 29886021
-
Curcumin inhibits the proteasome activity in human colon cancer cells in vitro and in vivo.Cancer Res. 2008 Sep 15;68(18):7283-92. doi: 10.1158/0008-5472.CAN-07-6246. Cancer Res. 2008. PMID: 18794115 Free PMC article.
-
A New Water-Soluble Nanomicelle Formed through Self-Assembly of Pectin-Curcumin Conjugates: Preparation, Characterization, and Anticancer Activity Evaluation.J Agric Food Chem. 2017 Aug 16;65(32):6840-6847. doi: 10.1021/acs.jafc.7b02250. Epub 2017 Jul 30. J Agric Food Chem. 2017. PMID: 28721737
-
Curcumin: from ancient medicine to current clinical trials.Cell Mol Life Sci. 2008 Jun;65(11):1631-52. doi: 10.1007/s00018-008-7452-4. Cell Mol Life Sci. 2008. PMID: 18324353 Free PMC article. Review.
-
Clinical development of novel proteasome inhibitors for cancer treatment.Expert Opin Investig Drugs. 2009 Jul;18(7):957-71. doi: 10.1517/13543780903002074. Expert Opin Investig Drugs. 2009. PMID: 19505187 Free PMC article. Review.
Cited by
-
Effects of curcumin and ursolic acid in prostate cancer: A systematic review.Urologia. 2024 Feb;91(1):90-106. doi: 10.1177/03915603231202304. Epub 2023 Sep 30. Urologia. 2024. PMID: 37776274 Free PMC article. Review.
-
Evolution of Natural Product Scaffolds as Potential Proteasome Inhibitors in Developing Cancer Therapeutics.Metabolites. 2023 Mar 31;13(4):509. doi: 10.3390/metabo13040509. Metabolites. 2023. PMID: 37110167 Free PMC article. Review.
-
Enhancing curcumin's solubility and antibiofilm activity via silica surface modification.Nanoscale Adv. 2020 Mar 20;2(4):1694-1708. doi: 10.1039/d0na00041h. eCollection 2020 Apr 15. Nanoscale Adv. 2020. PMID: 36132306 Free PMC article.
-
Synthesis of new curcumin-based aminocarbonitrile derivatives incorporating 4H-pyran and 1,4-dihydropyridine heterocycles.Mol Divers. 2021 Nov;25(4):2123-2135. doi: 10.1007/s11030-020-10104-3. Epub 2020 May 17. Mol Divers. 2021. PMID: 32419085
-
Targeting the ubiquitin-proteasome system for cancer treatment: discovering novel inhibitors from nature and drug repurposing.Cancer Metastasis Rev. 2017 Dec;36(4):717-736. doi: 10.1007/s10555-017-9705-x. Cancer Metastasis Rev. 2017. PMID: 29047025 Free PMC article.
References
-
- Ammon HPT, Wahl MA. Pharmacology of curcuma-longa. Planta Medica. 1991;57:1–7. - PubMed
-
- Aggarwal BB, Sundaram C, Malani N, Ichikawa H. Curcumin: the Indian solid gold. Adv Exp Med Biol. 2007;595:1–75. - PubMed
-
- Landis-Piwowar KR, Milacic V, Chen D, Yang H, Zhao Y, Chan TH, Yan B, Dou QP. The proteasome as a potential target for novel anticancer drugs and chemosensitizers. Drug Resist Update. 2006;9:263–273. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
